Cargando…
Inhalational Gentamicin Treatment Is Effective Against Pneumonic Plague in a Mouse Model
Pneumonic plague is an infectious disease characterized by rapid and fulminant development of acute pneumonia and septicemia that results in death within days of exposure. The causative agent of pneumonic plague, Yersinia pestis (Y. pestis), is a Tier-1 bio-threat agent. Parenteral antibiotic treatm...
Autores principales: | Gur, David, Glinert, Itai, Aftalion, Moshe, Vagima, Yaron, Levy, Yinon, Rotem, Shahar, Zauberman, Ayelet, Tidhar, Avital, Tal, Arnon, Maoz, Sharon, Ber, Raphael, Pass, Avi, Mamroud, Emanuelle |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5928325/ https://www.ncbi.nlm.nih.gov/pubmed/29740404 http://dx.doi.org/10.3389/fmicb.2018.00741 |
Ejemplares similares
-
Circumventing Y. pestis Virulence by Early Recruitment of Neutrophils to the Lungs during Pneumonic Plague
por: Vagima, Yaron, et al.
Publicado: (2015) -
Host Iron Nutritional Immunity Induced by a Live Yersinia pestis Vaccine Strain Is Associated with Immediate Protection against Plague
por: Zauberman, Ayelet, et al.
Publicado: (2017) -
Rapid Induction of Protective Immunity against Pneumonic Plague by Yersinia pestis Polymeric F1 and LcrV Antigens
por: Aftalion, Moshe, et al.
Publicado: (2023) -
Phage Therapy Potentiates Second-Line Antibiotic Treatment against Pneumonic Plague
por: Vagima, Yaron, et al.
Publicado: (2022) -
Targeting of the Yersinia pestis F1 capsular antigen by innate-like B1b cells mediates a rapid protective response against bubonic plague
por: Levy, Yinon, et al.
Publicado: (2018)